New Delhi: The findings from a crucial clinical trial that may transform hypertension management in India have shown that two-drug combinations of three widely used medicines used in patients with ...

A peptide hormone produced in the brain that triggers physiological reproductive responses has been 'hacked' by scientists to ...

The pathology and radiology giant is recovering from its post-pandemic malaise and says earnings should improve this year ...

Atrial fibrillation, or Afib, is the most common type of heart arrhythmia. Afib increases your risk of heart attack and ...

Levine Children's Hospital has several experimental treatments that help families get lifesaving care without having to leave ...

A year ago, there was 1 drug for idiopathic pulmonary fibrosis in trials at Temple Health. Now there are 10 active trials and 8 more coming up.

Fate Therapeutics (FATE) presented initial clinical and translational data from the company’s Phase 1 study of FT522 in relapsed / refractory ...

Eli Lilly said the treatment, a once-daily pill called muvalaplin, showed reductions in Lp (a) levels compared to placebo. Injectables are currently in Phase 3 development, but "these are the first ...

Jaime Merchan, MD, discusses the background and findings from the LITESPARK-013 trial of belzutifan for the treatment of patients with advanced clear cell renal cell carcinoma.

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

A revolutionary breakthrough in cataract treatment is on the horizon, with the emergence of C-KAD, a new eye drop therapy.

In positive early data from the RCT, sacubitril/valsartan given over 24 weeks reduced signs of heart damage in cancer ...